Can a smart patch replace a pill for temperature monitoring?
NCT ID NCT07397988
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This small study with 12 adults checks if wearable temperature sensors can collect reliable data when compared to an ingestible capsule that measures core body temperature. Participants wear the sensors and swallow the capsule for about 48 hours. The goal is to see if the process works smoothly and the data stays accurate—no treatment or diagnosis is involved.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 12 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Mar 2026
An estimate. Start dates often move.
- Expected to finish
-
Mar 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult participants (≥18 years) capable of providing informed consent and willing to comply with the project procedures, including ingestion of the capsule and continuous wearing of two wearable devices for around 48 hours until capsule excretion under free-living conditions.
- Ages
-
18 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Written informed consent obtained prior to any project-specific procedures. * Age 18 years or older at enrolment. * Able and willing to comply with project procedures, including capsule ingestion, continuous wearable use for around 48 hours, and adherence to study instructions. * Able to swallow the ingestible temperature capsule without difficulty. * No contraindication to ingestible thermometry as assessed by the investigator. Exclusion Criteria: General: * Body weight \< 36 kg. * Women who are pregnant. * Participation in another clinical investigation involving an investigational medicinal product or medical device within the 30 days preceding enrolment or previous enrolment in the current project. * Enrolment of the Principal Investigator, project staff, their family members, employees, or other dependent persons. * Inability to provide valid informed consent or significant language barrier preventing adequate understanding of procedures. Implants \& MRI: * Presence of any active Implantable Medical Device (AIMD), including Pacemakers, Implantable Cardioverter Defibrillators (ICDs), Deep Brain Stimulation (DBS) devices, or Left Ventricular Assist Devices (LVADs). * Requirement for MRI scanning during the seven days following the capsule intake. Cognitive/Physical Status: * Unconscious patients (prior to ingestion). * Patients with special needs or disabilities preventing safe autonomous swallowing. Gastrointestinal: * Known history of dysphagia or gag reflex troubles. * Previous gastrointestinal surgery resulting in bowel stenosis. * Current or planned surgical procedures on the GI tract (esophagus, stomach, intestines). * Zenker's diverticulum or felinization of the esophagus. * Risk or history of intestinal obstruction, strictures, or diverticula. * Hypomotility disorders (e.g., ileus). * Inflammatory Bowel Diseases including Crohn's disease or Ulcerative Colitis. Dermatological Exclusions (Rheo Vital+ Performance) * Dermatological conditions, wounds, tattoos, oedema, inflammation, active venous access, or other impairments at the medial upper arm or axillary region that could interfere with correct placement or functioning of the wearable device. * Excessive hair or concurrent devices that hinder correct sensor placement. * Known allergy to plastics or latex. Temperature Management: * Active external heating or cooling (e.g., cooling blankets). * Note: Use of pharmacological antipyretics (oral/IV) is permitted. Further Medical Conditions: * Currently existing acute back pain. * Symptomatic herniated disc.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Temperature change, body are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University Hospital Basel
Basel, 4031, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tracking body heat during cardiac arrest improve survival?
- Can a No-Touch thermometer match the Old-School kind?
- Can a wristband replace a pill for temperature checks?
- How much heat can older women take? scientists aim to find out
- Spinal anesthesia study reveals temperature effects of common sedatives
- Hijab and heat: small study tests exercise risks for muslim women